Leta i den här bloggen


måndag 9 juli 2018

Suomalainen sirtuiinikatsaus 2014

(Katsaus näyttää olevan maksullinen ja se on hankittavissa allaolevasta lähteestä. Tiivistelmä ja sisälysluettelo on kuitenkin tarjolla)

Research and Clinical Interventions
2014, Pages 323-332
Chapter 27 - Inflammaging Signaling in Health Span and Life Span Regulation: Next Generation Targets for Longevity
Abstract
The aging process is associated with a low-grade local and systemic inflammation, a condition called inflammaging. The major molecular hallmarks of the aging process include a decline in the autophagic cellular clearing capacity and an increase in NF-κB signaling, a key activator of inflammation. Interestingly, longevity-promoting proteins, e.g. AMPK, SIRT1, and FOXO, are inducers of autophagy and suppressors of NF-κB signaling. These longevity factors also regulate the dietary restriction-induced increase in health span and life span, and thus they are promising drug targets for anti-aging medicine. We will briefly review current knowledge about the signaling network controlling the aging process and evaluate drug discovery approaches to developing anti-aging medications.
Keywords
aging
autophagy
inflammation
life span
longevity
AMPK
NF-κB
SIRT1
Outline
  1. Abstract
  2. Keywords
  3. Acknowledgments
  4. Introduction
  5. Inflammaging
  6. Signaling Network Controlling the Aging Process
    • Insulin/IGF-I-FOXO Pathway
    • AMP-Activated Protein Kinase Signaling
    • Sirtuin Signaling
    • Nuclear Factor-Kappa-B Signaling
  7. Dietary Restriction and Extension of Life Span
  8. Potential Targets for Anti-Aging Medicine
    • Activation of Autophagy
      • AMP-Activated Protein Kinase Activators
      • SIRT1 Activators
      • mTOR Inhibitors
      • Other Factors
    • Suppression of Local and Systemic Inflammation
      • The Senescence-Associated Secretory Phenotype
      • Inhibition of Nuclear Factor-Kappa-B Signaling and Inflammation
  9. Magic Bullets Without Potency
    • Oxidative Stress and Antioxidants
    • Hormone Replacement Therapies
  10. Conclusions
  11. References
 

Inga kommentarer:

Skicka en kommentar